首页> 外国专利> PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA USING PENTAMIDINE IN AEROZOL FORM

PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA USING PENTAMIDINE IN AEROZOL FORM

机译:以戊胺形式的戊胺预防肺卡氏肺炎的预防。

摘要

PURPOSE: To prevent/treat pneumocystis carinii pneumonia(PCP) without any concomitant significant toxic reaction by administering pentamidine in the form of aerosol spray with specific particulate size. CONSTITUTION: A patient subject to or already affected by PCP is administered with an effective dose of pentamidine; p,p'-(pentamethylenedioxy)dibenzamidine or a pharmaceutically permissible salt thereof (e.g. isethionate) in the form of aerosol spray with particulate size being 0.5-8.0m in aerodynamic diameter. For the aerosol spray, particulates each 0.5-8m in diameter preferably account for =55wt.% of the whole particulates, and the mass median aerodynamic diameter is pref. 1-6 (esp. 1-4); and the aerosol spray is preferably produced by the use of an ultrasonic nebulizer. The dose of the pentamidine is 1-200 (pref. 45-75)mg for preventing PCP.
机译:目的:预防/治疗卡氏肺孢子虫性肺炎(PCP),而无任何明显的毒性反应,方法是喷洒具有特定颗粒大小的喷洒形式的喷他idine。组成:患有或已经受PCP影响的患者接受有效剂量的喷他idine。 p,p'-(五亚甲基二氧基)二苯甲m或其可药用盐(例如羟乙磺酸盐)呈气雾剂形式,其气动力学粒径为0.5-8.0m。对于气雾剂喷雾,每个直径为0.5-8m的颗粒优选占全部颗粒的≥55wt。%,并且质量中值空气动力学直径是优选的。 1-6(尤其是1-4);并且优选通过使用超声雾化器产生气雾剂。为了预防PCP,喷他idine的剂量为1-200(优选45-75)mg。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号